Ebola (*) vaccine developed by the Gamaleya Center
MERS (Middle East Respiratory Syndrome)* candidate vaccine developed by the Gamaleya Center
Start of work on Sputnik V (*)
Vaccine developed by the Gamaleya Center
03/08/2020
Completion of phase 1-11 of clinical trials
11/08/2020
Vaccine registration in Russia
Launch of unprecedented post-registration multinational Phase Ill clinical triaIs
on over 44,000 volunteers
Start of mass vaccine production in Russia
Start of global vaccine supplies
Global supply of vaccine over 1 bn doses
4HumansCare